February 2025 in “The Indian Journal of Pediatrics” Siddha therapeutics successfully treated a 14-year-old's alopecia areata, leading to full hair regrowth without side effects.
1 citations
,
March 2025 in “Journal of Drug Delivery and Therapeutics” This review found that Seenthil Chooranam, a traditional Siddha formulation, has potential therapeutic benefits for various diseases due to its pharmacological properties and bioactive compounds, though further research is needed to confirm its safety and clinical effectiveness.
June 2026 in “International Journal of Pharmaceutical Sciences Review and Research” In this case report, Siddha therapies, including internal and external treatments, effectively reduced patchy hair loss and improved psychological well-being in a 23-year-old male with alopecia areata, without adverse effects; however, further studies are needed to confirm these findings.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review compiles existing knowledge on the traditional uses, phytochemistry, and pharmacological activities of Eclipta alba, a plant with potential health benefits traditionally used in Ayurveda and other healing systems, encouraging further exploration of its therapeutic potential.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review compiles existing knowledge on the botanical characteristics, traditional uses, phytochemistry, and pharmacological activities of Eclipta alba, highlighting its potential therapeutic properties and encouraging further pharmacological and phytochemical exploration of this traditionally used medicinal plant.